Panbela Therapeutics Inc (PBLA)

Currency in USD
0.1579
0.0000(0.00%)
Delayed Data·
PBLA Scorecard
Full Analysis
Stock generally trades with high price volatility
PBLA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.15790.1579
52 wk Range
0.05000.4729
Key Statistics
Prev. Close
0.1579
Open
0.1579
Day's Range
0.1579-0.1579
52 wk Range
0.05-0.4729
Volume
-
Average Volume (3m)
14.54K
1-Year Change
-53.28%
Book Value / Share
-3.74
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PBLA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Panbela Therapeutics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Panbela Therapeutics Inc Company Profile

Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of disruptive therapeutics for the treatment of patients with urgent unmet medical needs. The company’s lead product candidates are Ivospemin (SBP-101), a proprietary polyamine analogue, which has completed Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma; Flynpovi, a combination of eflornithine (CPP-1X) and sulindac which is in Phase III clinical trials; and Eflornithine, an enzyme-activated irreversible inhibitor of the enzyme ornithine decarboxylase, currently under Phase I/II trial. It has a research agreement with the Johns Hopkins University School of Medicine for the development of ivospemin. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.

Compare PBLA to Peers and Sector

Metrics to compare
PBLA
Peers
Sector
Relationship
P/E Ratio
0.0x−4.5x−0.5x
PEG Ratio
0.00−0.180.00
Price/Book
0.0x−0.5x2.6x
Price / LTM Sales
-0.1x3.2x
Upside (Analyst Target)
-10,600.0%41.2%
Fair Value Upside
Unlock4.4%6.2%Unlock

Earnings

Latest Release
Nov 14, 2024
EPS / Forecast
-1.48 / -15.00
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

PBLA Income Statement

FAQ

What Stock Exchange Does Panbela Therapeutics Trade On?

Panbela Therapeutics is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Panbela Therapeutics?

The stock symbol for Panbela Therapeutics is "PBLA."

What Is the Panbela Therapeutics Market Cap?

As of today, Panbela Therapeutics market cap is 766.58K.

What Is Panbela Therapeutics's Earnings Per Share (TTM)?

The Panbela Therapeutics EPS (TTM) is -11.31.

From a Technical Analysis Perspective, Is PBLA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Panbela Therapeutics Stock Split?

Panbela Therapeutics has split 4 times.

How Many Employees Does Panbela Therapeutics Have?

Panbela Therapeutics has 8 employees.

What is the current trading status of Panbela Therapeutics (PBLA)?

As of 29 Jul 2025, Panbela Therapeutics (PBLA) is trading at a price of 0.16, with a previous close of 0.16. The stock has fluctuated within a day range of 0.16 to 0.16, while its 52-week range spans from 0.05 to 0.47.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.